Page last updated: 2024-08-23

azoxymethane and trinitrobenzenesulfonic acid

azoxymethane has been researched along with trinitrobenzenesulfonic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL1
Bak, AW; Devchand, PR; Wallace, JL; Zamuner, SR1
Arber, N; Brazowski, E; Elinav, E; Hart, G; Maharshak, N; Margalit, R; Ron, E; Sagiv, A; Shachar, I; Zelman, E1
Gadaleta, RM; Garcia-Irigoyen, O; Moschetta, A1
Dai, X; Gui, G; Li, K; Liu, J; Xiao, Y; Yang, H1

Other Studies

5 other study(ies) available for azoxymethane and trinitrobenzenesulfonic acid

ArticleYear
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
    Life sciences, 1998, Volume: 62, Issue:23

    Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid

1998
Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2.
    The American journal of pathology, 2005, Volume: 167, Issue:5

    Topics: Animals; Azoxymethane; beta Catenin; Colitis; Colon; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Susceptibility; Intramolecular Oxidoreductases; Lipocalins; Male; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Immunologic; Receptors, Prostaglandin; Trinitrobenzenesulfonic Acid

2005
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:9

    Topics: Animals; Azoxymethane; Blotting, Western; Carcinogens; Cell Adhesion; Cell Movement; Cell Proliferation; Chemokine CCL2; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Trinitrobenzenesulfonic Acid

2010
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
    Current protocols in mouse biology, 2017, Mar-02, Volume: 7, Issue:1

    Topics: Acute Disease; Animals; Azoxymethane; Cell Transformation, Neoplastic; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid

2017
Clostridium butyricum partially regulates the development of colitis-associated cancer through miR-200c.
    Cellular and molecular biology (Noisy-le-Grand, France), 2017, Apr-29, Volume: 63, Issue:4

    Topics: Animals; Azoxymethane; Carcinogenesis; Cell Proliferation; Clostridium butyricum; Colitis; Colonic Neoplasms; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization, Fluorescence; Inflammation; Interleukin-12; Mice; MicroRNAs; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2017